Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Oct 17.
Published in final edited form as: Inorg Chem. 2011 Sep 9;50(20):10124–10133. doi: 10.1021/ic201076w

Reactions of the Fluorescent Sensor, Zinquin, with the Zinc-proteome: Adduct Formation and Ligand Substitution

Andrew B Nowakowski 1, David H Petering 1,*
PMCID: PMC3230276  NIHMSID: NIHMS323781  PMID: 21905645

Abstract

Zinquin (ZQ) is a commonly used sensor for cellular Zn2+ status. It has been assumed that measures accessible Zn2+ concentrations in the nmolar range. Instead, this report shows a consistent pattern across seven mammalian cell and tissue types that ZQ reacts with micromolar concentrations of Zn2+ bound as Zn-proteins. The predominant class of products were ZQ-Zn-protein adducts that were characterized in vivo and in vitro by a fluorescence emission spectrum centered at about 470 nm, by their migration over Sephadex G-75 as protein not low molecular weight species, by the exclusion of reaction with lipid vesicles, and by their large aggregate concentration. In addition, variable, minor formation of Zn(ZQ)2 with a fluorescence band at about 490 nm was observed in vivo in each case. Because incubation of isolated Zn-proteome with ZQ also generated similar amounts of Zn(ZQ)2, it was concluded that this species had formed through direct ligand substitution in which ZQ had successfully competed for protein-bound Zn2+. Parallel studies with the model Zn-proteins, alcohol dehydrogenase (ADH) and alkaline phosphatase (AP) revealed a similar picture of reactivity: ZQACID able to bind to one Zn2+ and extract the other in Zn2-ADH, whereas it removed one Zn2+ from Zn2-AP and did not bind to the other. ZQETHYL ESTER bound to both proteins without sequestering Zn2+ from either one. In contrast to a closely related sensor, TSQ, neither ZQACID nor ZQEE associated with Zn-carbonic anhydrase. A survey of reactivity of these sensors with partially fractionated Zn-proteome confirmed that ZQ and TSQ bind to distinct, overlapping subsets of the Zn-proteome.

Introduction

The participation of Zn2+ in biological systems is both large and diverse. Bioinformatic analysis indicates that nearly 10% of the human genome codes for potential zinc-binding proteins.1 The roles of Zn2+ in these proteins vary from structural stabilization as seen in Zn-finger transcription factors to involvement as a catalytic cofactor in hundreds of enzymes such as carbonic anhydrase and carboxypeptidase.1,2 Besides these traditional roles, elevated intracellular Zn2+ concentrations can interact with other proteins to induce the synthesis of structures such as metallothionein.3 Additionally, high levels of Zn2+ in synaptic vesicles and its mobilization under certain conditions have suggested that Zn2+ may act as a neurotransmitter.4,5 Moreover, nutrient Zn2+ deficiency rapidly alters cell metabolism.6,7 Thus, understanding Zn2+ distribution and trafficking within biological systems is central to grasping the contributions of Zn2+ to cellular metabolism.

Fluorescent probes have emerged as the researcher’s main tool in studying basal and transient changes in labile Zn2+ in a variety of tissues.815 Zn2+ sensors based on quinolinetoluenesulfonamide comprise a major class of such agents (Figure 1A). One of these probes is TSQ, a fluorescent dye that binds to free Zn2+ in a 2:1 stoichiometry.16 This molecule was first used as a histochemical stain to image Zn2+ within the central nervous system.9 Another Zn2+ fluorophore, Zinquin or ZQ, has replaced TSQ in common use (Figure 1A and B).13 It was introduced to overcome a perceived shortcoming of TSQ, namely, its zero charge that may permit cellular efflux of the probe. Moreover, because Zn(TSQ)2 also bears no charge, it, too, might diffuse out of cells. In an attempt to circumvent these possible problems, an ethyl ester moiety was added to the methoxy group at the 8 position of the quinoline ring (Figure 1A). Like TSQ, ZQEE, the ethyl ester compound, readily permeates the cell membrane. However, once inside, it undergoes hydrolysis catalyzed by intracellular esterases to yield the negatively charged acid, ZQACID, that ideally is fixed within the cell either as the free ligand or as Zn(ZQACID)2 (Figure 1B). It should be noted, however, that this negatively charged species has been shown to have some degree of permeability through both plasma membranes and unilamellar liposomes.17 In combination with the addition of the ethyl ester, the location of a methyl group at the 2 position enhances Zinquin’s affinity for Zn2+ so that it may sense smaller intracellular fluxes of Zn2+ than TSQ.16

Figure 1.

Figure 1

A) Chemical structure of various quinoline-based fluorescent probes for sensing Zn2+. B) Chemical structure of Zn(ZQAcid)2.

It has been assumed that sensors (S) such as TSQ and ZQ react with Zn-ligand complexes (Zn-L) to form fluorescent products:

Zn-L+2SZnS2+L    (K,k) (1)

Zn-L includes Zn-proteins, small molecular weight complexes, and Zn2+. The nature of Zn-L that is accessible to S depends on the thermodynamic (K) and kinetic (k) feasibility of reaction 1.18 Despite their common use, little detail is known about the intracellular reactions of quinolinetoluenesulfonamide Zn2+ sensors.

Recently, experiments were undertaken to clarify the nature of the reactions of TSQ with cells.19 It was determined that TSQ reacts primarily with components of the Zn-proteome by forming ternary adducts (reaction 2) not by generating Zn(TSQ)2.

Zn-P+TSQTSQZn-P (2)

Thus, TSQ images the cellular distribution of a subset of the Zn-proteome not Zn2+ or Zn2+ donated to TSQ through its reaction with Zn-proteins or other sources of Zn2+ (reaction 1).

It might be hypothesized that TSQ and ZQACID behave similarly and form ternary adduct species with cellular Zn-proteins. However, some chemical properties of the two fluorophores differ from one another. ZQACID binds Zn2+ several orders of magnitude more strongly than TSQ, a property that might favor the formation of Zn(ZQACID)2.20,21 Moreover, negatively charged ZQACID might find different sites of reaction than TSQ. Thus, it was important to investigate the characteristics of reaction of ZQEE with cells and to compare them with TSQ. The present study demonstrates that while TSQ and ZQEE share themes of reactivity with cells, they differ in key ways. As a result, they are seen as complementary in their reactions with members of the Zn-proteome.

Materials and Methods

Chemical reagents

Zinquin Ethyl Ester (ZQEE) and Zinquin Acid (ZQACID) were obtained from Enzo Life Sciences (Plymouth Meeting, PA). 6-methoxy-(8-p-toluenesulfonamido) quinoline (TSQ) was obtained from AnaSpec (Fremont, CA). Sensors were solubilized in DMSO at stock concentrations of 12 mM and stored in the dark at 4 °C. All other chemicals were obtained from either Sigma-Aldrich or Fisher Scientific (Milwaukee, WI).

Cell lines

All cell lines were purchased from the American Tissue Culture Company. Each was cultured as follows: pig kidney cells in level 1 culture (LLC-PK1) in Medium 199 (Sigma) supplemented with 4% fetal calf serum (FCS); human medulloblastoma cells (TE671) in Dulbecco’s Minimal Essential Growth-Low Glucose media (Sigma) supplemented with 5% FCS; human brain glioblastoma cells (U87 mg) in Eagles’ Minimal Essential Media supplemented with 5% FCS; rat brain glioma cells (C6) in Ham’s F-12 Nutrient Mixture-Kaighn’s Modification media (Sigma) supplemented with 15% horse serum and 2.5% FCS; human epithelial lung carcinoma cells (A549) in Ham’s F-12 Nutrient Mixture (Sigma) supplemented with 10% FCS; and human lymphocytic leukemia cells (CCRF-CEM) in suspension in RPMI 1640 media (Sigma) supplemented with 10% FCS. All media were additionally supplemented with 50 mg/L penicillin G and 50 mg/mL streptomycin. LLC-PK1, A549 and C6 Cells were incubated in the presence of 5% CO2 at 37° C, while TE671, U87 mg and CCRF-CEM cells were maintained in the presence of 6% CO2 at 37° C. Media were changed every 48–72 hours until confluency was reached. Cultures were subdivided either by dilution in new complete media (CCRF-CEM) or by trypsin/EDTA treatment (LLC-PK1, U87 mg, TE671, C6, A549).

Mixed neuron-astrocyte cell suspensions from the cortex region—as well as the remainder of the brain—were isolated from fetal mice after 15–16 days of gestation. Pregnant mice were anesthetized with isoflurane and euthanized. Fetal brains from 7–8 pups were isolated in 3 mL of Eagles’ Minimal Essential Media. Suspensions were prepared by mechanical tissue disruption and were washed 3 times in Dulbecco’s Phosphate Buffered Saline (DPBS, Sigma) to further fragment the tissue. The final preparation contained about 90% neurons.

Fluorescent spectroscopy of cells

Cultured cells were grown in 100mm culture plates to confluence. Culture media were decanted and plates were washed three times in cold DPBS. Cells were then suspended in DPBS by gently scraping with a rubber cell scraper. Fluorescent spectroscopy of the resultant suspension was performed using an Hitachi F-4500 fluorescent spectrophotometer. Emission spectra were recorded from 400–600nm with an excitation wavelength of 370nm using 10/5.0 nm excitation/emission slit widths. ZQEE (25 µM) was added to the suspension and allowed to incubate for 30 minutes and additional spectra were taken.22

Separation of cell lysates and isolation of the Zn-proteome

Cells were collected by centrifugation at 680 × g for 4 min, washed once in DPBS and finally resuspended in 1 mL cold double distilled H2O. Cells were lysed via sonication and centrifuged at 47,000 × g for 20 minutes at 4 °C. The lysate—also referred to as the cell supernatant—was loaded onto an 80 cm × 0.75 cm Sephadex G-75 (GE Healthcare) gel filtration column and eluted with degassed 20 mM Tris-Cl, pH 7.4. 50 1 mL fractions were collected. Fluorescence spectra of all fractions were recorded as noted above. For cells not exposed to Zinquin, 10 µM ZQACID was added to each fraction before fluorescence readings. The Zn2+ concentration of each fraction was determined by flame atomic absorption spectroscopy (AAS).

To isolate the Zn-Proteome, unexposed cells were fractionated as described above. Fractions within the high molecular weight region containing absorbance at 280 nm were pooled and Zn2+ concentration was determined by AAS. The resultant pooled fractions were then referred to as the Zn-proteome.

Titration of Zn-proteome with Zinquin

The initial fluorescence of the isolated Zn-Proteome was recorded as the background fluorescence. 10 µM Zn-proteome was titrated with 1 µM ZQEE/ ZQACID with final additions of 2.5 and 5 µM to a final concentration of 20 µM ZQ. Reactions were incubated for 15 minute in between additions. After titration, the reaction mixture was loaded onto a 40 cm × 0.75 cm Sephadex G-50 (GE Healthcare) gel filtration column and eluted with degassed 20 mM Tris-Cl buffer, pH 7.4. Thirty 1 mL samples were collected. Fluorescence and Zn2+ concentrations of the eluted fractions were recorded as noted.

Approximately 10 µM (based on Zn2+) of isolated proteome from LLC-PK1 and TE671 cells were reacted with 0.1 mM EDTA for 30 minutes. The Zn-proteome was then run over a Sephadex G-50 column eluted with degassed 20 mM Tris-Cl buffer pH 7.4. Thirty 1 mL fractions were collected and reacted with 10 µM ZQACID for 30 minutes before fluorescence and Zn2+ were determined as previously noted.

Fluorophore reactivity of Zn-proteome from TE671 cells

TE671 cells were collected, washed and sonicated as previously noted. The sonicate was centrifuged at 100,000 × g for 40 minutes at 4 °C. The Zn-proteome was isolated by subjecting the resulting supernatant to centrifugation through a Millipore Centricon Centrifuge filter (30,000 MW cut off) at 4700 × g at 4 °C. The retentate was washed with degassed 20 mM Tris-Cl pH 8.0 and re-centrifuged three times until the conductivity was that of the starting buffer. The Zn-proteome was loaded onto three conjoining Macro-Prep DEAE ion exchange columns (Bio-Rad) and eluted using degassed 20 mM Tris-Cl pH 8.0 with a salt gradient from 0 to 500 mM NaCl. 100 1 mL fractions were collected, divided in two, and initial background fluorescence was recorded. Fractions were then reacted with 5 µM ZQACID or 5 µM TSQ for 30 minutes and additional spectra were taken and background fluorescence was subtracted.

The supernatant of sonicated TE671 cells after centrifugation at 100,000 × g for 40 minutes at 4 °C was loaded onto a 60 cm × 1.5 cm Sephacryl S-300 (Sigma) gel filtration column. The column was eluted with degassed 50 mM Tris-Cl pH 7.4 containing 150 mM NaCl. The flow rate was set for 1.0 mL/min and 110 1 mL fractions were collected. Each fraction was reacted with 5 µM ZQACID for 30 minutes before fluorescence was recorded. To determine approximate molecular masses of the proteins within the elution fractions, gel filtrations standards (Bio-Rad) containing thyroglobulin (670,000 Da), gamma-globulin (158,000 Da), albumin (44,000 Da), myoglobin (17,000 Da), and vitamin B12 (1,350 Da) were ran under the same elution conditions.

Titrations of Zinquin with model proteins

Yeast alcohol dehydrogenase (Worthington Biochemical Corporation) was prepared by dissolving the lyophilized powder in degassed 20 mM Tris-Cl buffer, pH 7.4. Bovine alkaline phosphatase (Sigma-Aldrich) was similarly prepared in degassed 50 mM HEPES buffer, pH 7.4. Bovine erythrocyte carbonic anhydrase (Sigma-Aldrich) was solubilized in degassed 50 mM Tris-Cl buffer, pH 8.0. After preparation, 10 µM Carbonic anhydrase (Zn-CA), alkaline phosphatase (Zn2-AP) or alcohol dehydrogenase (Zn2-ADH) were titrated with 1 µM aliquots of ZQACID or ZQEE until maximum fluorescence was reached. Samples were then eluted using Sephadex G-50 gel filtration. Fluorescence and Zn2+ concentration of eluted fractions were recorded as noted above.

Results

Reactions of ZQEE with cells

The fluorophore Zinquin was used in conjunction with fluorescence spectroscopy to detect Zn2+ within cultured cells. To investigate the generality of Zinquin-induced fluorescence, a variety of cell types were used in this study (Table 1). Because of the interest in Zn2+ distribution and trafficking in the brain, glioblastomal U87 mg and medulloblastoma TE671 cell lines were included as models for Zinquin exposure.4,5,23 An immortalized pig kidney cell line (LLC-PK1) was examined because of previous reports of the reactivity of its Zn-proteome.19,24 Microscopic studies of the interaction of Zinquin with C6 and A549 cells have been done previously, so these cell types were also used in this investigation.10,12,15 A lymphocytic cell line, CCRF-CEM, which grows in suspension, was also examined for comparison with adherent cells.

Table 1.

Cell models used for fluorescence spectroscopy of Zinquin and emission properties of exposed cells.

Cell line, Species Tissue Growth Properties Zinquin
Fluorescence1
λmax (nm)
LLC-PK1, Sus scofa (pig) Kidney Epithelial adherent 39.8±4.1 471
TE-671, Homo sapien (human) Medulloblastoma adherent 165.1±8.7 471
U-87 MG, Homo sapien (human) Glioblastoma adherent 153.2±9.5 475
C6, Rattus norvegicus (rat) Brain Glioma adherent 78.9±8.2 473
CCRF-CEM, Homo sapien (human) T-Cell Lymphoblast suspension 68.0±1.9 471
A549, Homo sapien (human) Lung Carcinoma adherent 83.7±10.8 473
Mouse, Mus muculus (Swiss-Webster) Whole Brain, > 9:1 neuron: astrocyte suspension of primary dissection 46.7 474
1

5×106 cells/mL, sum of fluorescence from 400–600 nm in thousand units, n=3, except for mouse whole brain cells where n=1.

Figure 2 depicts the changes in fluorescence intensity of the different cell lines after exposure to ZQEE. The total fluorescence emission intensity normalized either to number of cells (5 × 106 cells/mL) or to protein content was unique to the cell type, suggesting Zinquin senses differing amounts of Zn2+ in each system. Nevertheless, all cell lines show emission spectra that place λmax near 470 nm. These emission spectra are different from the expected emission spectrum of free Zn2+ bound to ZQACID, which displays a λmax of 492nm (Figure 2h).13 It is hypothesized that ZQACID may react with open coordination sites of Zn-proteins to form ternary adducts instead of reacting with ‘free’ Zn2+ to produce Zn(ZQACID)2 resulting in emission spectra that are blue-shifted from 490nm to 470nm (Reaction 3).19,25

ZQACID+Zn-ProteinZQACIDZn-Protein (3)

Figure 2.

Figure 2

Fluorescence spectra of ZQ-exposed cells in comparision to 1 µM of Zn(ZQ)2. 5 × 106 TE671(a), U87 mg(b), A549(c), C6(d), CCRF-CEM(e), Mouse Brain(f) and LLC-PK1 (g) cells were suspended in DPBS and reacted with 25 µM Zinquin Ethyl Ester for 30 minutes before fluorescence was recorded using a 370 nm excitation. Spectra from all cell lines show emission profiles that are blue-shifted to 470 nm from the normal emission maximum of 492 nm for Zn(ZQ)2 (h).

Fluorescence and Zn2+ distribution of exposed cells

To investigate where the fluorescence is located within cells, ZinquinEE-exposed cell lysates were eluted using Sephadex G-75 gel filtration to separate the cellular components into three different pools:19,26,27 the proteomic region containing molecules >10kDa, metallothionein (MT) fractions (≈10kDa), and the low molecular weight (LMW) region including molecules <10kDa (Figure 3). Upon fractionation, nearly all of the fluorescence, thought to be due to the presence of ZQACID, formed in situ from ZQEE, was confined to the proteomic region of the chromatogram. The emission spectra of these proteomic fractions were characterized by λmax centered about 463 nm, displaying a major blue-shifted spectrum in comparison to Zn(ZQACID)2. The spectrum was similar to what was seen with intact cells. In addition, almost all of the Zn2+ in the lysates eluted with proteomic fractions and not in the LMW pool. These results are consistent with the hypothesis that ZQACID forms ternary ZQACID-Zn-protein adducts that elute with the proteome fractions.

Figure 3.

Figure 3

Fluorescence and Zn2+ distribution of Zinquin-exposed cells. 108 cells were incubated with 25 µM Zinquin Ethyl Ester before cytosolic fractionation via Sephadex G-75 gel filtration. Fractionation of LLC-PK1 (A) cells show localization of fluorescence and Zn2+ solely to the proteomic region of the chromatogram with no pool of LMW Zn2+ or fluorescence present. The TE671 (B) cells show the largest pool of LMW Zn2+ or fluorescence in all cell lines tested. U87 mg (C) cells were the only cells tested that contained measurable amounts of metallothionein (fractions 20–30) which were unreactive to treatment with Zinquin. Note: Since emission spectra profiles are unique to Zn-species (see text), fluorescence measurements were calculated as the integrated intensity from 400–600 nm.

Fluorescence intensities of the proteomic fractions were converted to Zn2+ concentrations using a standard curve based on the fluorescence emission of Zn(ZQACID)2. Comparing these values with the total Zn2+ concentrations measured by AAS shows that a differing amount of the proteome was reactive in each cell line (Table 2). The most reactive proteomes were those of the A549 cells and mouse brain, in which approximately 30% of the Zn2+ bound to the proteome appeared to coordinate with ZQACID. Conversely, the least reactive proteome was that of the U87 mg cells in which only 15% of the Zn2+ was sensed by ZQACID. Nevertheless, this range of values shows that substantial amounts of Zn2+ were accessed by ZQACID in all cells that were tested.

Table 2.

Survey of proteomic Zn2+ in multiple cell types exposed to 25 µM ZQEE.

Zn-Proteome Pool1
Cell Line Zn-AAS
(nmoles)
Fluorescence
(AU)2
Zn- Fluorescence
(nmoles)3
% Zn reacted λmax (nm)
LLC-PK14 23.6±2.1 48.3±12.6 4.2 18 462
C64 12.5±2.4 28.0±3.0 2.5 20 463
TE6714 50.1±4.9 112.2±12.1 9.9 20 464
U87 mg4 18.6±1.6 32.7±4.7 2.8 15 462
CCRF-CEM4 17.4±1.3 50.0±9.1 4.4 25 463
A5494 17.1±2.1 59.4±15.5 5.1 30 465
Mouse Brain 18.8 67.1 5.9 31 463
1

per 108 cells

2

sum of fluorescence from 400–600 nm in ten thousand units

3

amount of Zn2+ sensed by fluorescence based on a standard curve of titration of ZQAcid with Zn2+

4

average ± standard deviation of at least 3 replicates using different cell preparations

Table 2 also reveals that there are some notable differences in Zn2+ concentration among the seven types of cells that were analyzed. C6 and TE671 diverge markedly from the others based on normalization to either cell number or protein content. Interestingly, the percentage of total Zn2+ in the proteome that was sensed by ZQACID varied from 30 to 15%. This range was exhibited among the 5 cell types that displayed Zn2+ concentrations between 17–23 nmol/108 cells. Thus, either these cells contained markedly different sets of ZQACID-reactive Zn-proteins or other factors controlled access of ZQACID to these sites.

The U87 mg cell line was the only one that included a measurable amount of metallothionein (fractions 20–30 of Figure 3C). Metallothionein binds up to 7 Zn2+ ions, each with binding constants of about 1011.28 Unlike the proteome, the MT fractions did not show any fluorescence. Additionally, comparing ZQEE exposed and unexposed cells revealed that the amount of Zn2+ within these fractions was unperturbed under the two conditions (data not shown). When MT fractions from control cells were assayed with ZQACID, no increase in fluorescence was observed over a 30 minute period.

In some cases, LMW pools exhibited both fluorescence and Zn2+ ions. The extent of these pools varied between cell lines with TE671 cells containing the most fluorescence and Zn2+ and LLC-PK1 cells revealing no significant fluorescence or Zn2+ (Table 3). For the cell lines that contained LMW fluorescence, their spectra were identical with that expected for Zn(ZQACID)2 with a λmax centered around 492 nm (Figure 2h). In all cell lines, these pools were absent in unexposed cells that were first fractionated and then assayed with ZQACID for fluorescence (data not shown). This control experiment demonstrated that in cells ZQACID competed for proteomic Zn2+, sequestering Zn2+ from the proteome and then eluting as Zn(ZQACID)2 as proposed in Reaction 4.

2ZQACID+Zn-ProteinZn(ZQACID)2+apo-Protein (4)

Table 3.

Survey of LMW Zn pool in multiple cells types upon exposure to 25 µM ZQEE

LMW Zn Pool1
Cell Line Zn-AAS
(nmoles)
Fluorescence
(AU)2
% of Total
Zn
λmax (nm)
LLC-PK13 0.6 5.9 2 --
C64 1.5±0.3 10.0±2.2 11 491
TE6714 11.1±1.3 57.5±6.2 18 492
U87 mg4 2.9±0.6 19.8±8.7 9 493
CCRF-CEM4 1.3±0.4 17.8±2.7 6 491
A5494 2.2±0.6 19.0±5.4 11 492
Mouse Brain 1.5 21.0 7 492
1

per 108 cells

2

sum of fluorescence from 400–600 nm in ten thousand units

3

at limit of detection using flame atomic absorption spectroscopy

4

average ± standard deviation of at least 3 replicates using different cell preparations

Parallel studies with TSQ, the parent compound of Zinquin, were conducted. Upon exposure of each cell type in Table 1 to TSQ followed by Sephadex G75 fractionation of their cytosols, all of the fluorescence and Zn2+ was localized in the proteomic fractions with emission peak maxima in the 470nm range. Unlike ZQACID, TSQ was not able to compete for Zn2+ in the proteomic region to form Zn(TSQ)2.

Reactions of ZQEE/ZQAcid with the Zn-proteome

Since proteomic Zn2+ was solely responsive to ZQACID within cells, further characterization of the reaction of Zinquin with the isolated proteome was undertaken. The proteome of TE671 cells was isolated by size exclusion chromatography and reacted separately with ZQEE or ZQACID (Figure 4). In both cases, the fluorescence after exposure displayed blue-shifted emission spectra with a λmax of 470nm for ZQACID and 468nm for ZQEE.

Figure 4.

Figure 4

Titration of the Zn-proteome from TE671 cells with Zinquin Acid and Zinquin Ethyl Ester. The 10 µM (based on Zn2+) of the isolated proteome was titrated with increasing concentrations of Zinquin Acid (A) and Zinquin Ethyl Ester (B) in 20 mM Tris-Cl pH 7.4 at 25 °C. The maxiumum emission of these titrations were centered at 470 nm, similar to what is seen in intact cells. Sephadex G-50 fractionation of the reaction product show that the fluorescense stays with the proteome with both Zinquin Acid (C) and Zinquin Ethyl Ester (D).

When the reaction mixtures were chromatographed, fluorescence was observed in both the proteomic region and the LMW regions. The LMW pools from the ZQEE and ZQACID reactions were similar in both fluorescence intensity and Zn2+ concentration. These pools most likely represent reactive Zn2+ within the proteome that can undergo ligand substitution reaction with either Zinquin structure. The λmax of both these pools is 492nm, consistent with the formation of Zn(ZQACID)2. Since the spectra maximum of Zn(ZQEE)2 is centered at 481nm in a Tris buffer (data not shown), it appears that ZQEE had been hydrolyzed by proteomic esterases to form the acid and Zn(ZQACID)2.

Chromatography of lysates from cells or isolated Zn-proteome treated with ZQEE demonstrated that most of the fluorescence was confined to the proteomic fractions. These fluorescent fractions again showed blue-shifted emission spectra with a λmax of 468 and 466 nm for ZQACID and ZQEE, respectively. However, the fluorescence for the ZQEE-reacted proteome was approximately 20% higher than the ZQACID-exposed proteome. There are two possible reasons for this difference: (1) ZQEE reacted with more of the proteomic Zn2+ than ZQACID. Since the binding moieties are the same, it is likely this difference is attributed to the negative charge on ZQACID that may unfavorably interact with some Zn-proteins. (2) The quantum yield of ZQEE-Zn-Protein adducts are greater than that for ZQAcid-Zn-Protein adducts.

To test whether the reactive Zn2+ species in this pool labeled as the Zn-proteome was indeed Zn-proteins and not Zn2+ trapped within liposomal vesicles, the Zn-proteome isolated from LLC-PK1 cells was reacted with a 10 fold excess of EDTA (0.1 mM) and eluted over a G-50 size exclusion column. Since EDTA is not membrane permeant, any proteomic Zn2+ that undergoes ligand substitution with EDTA must be from kinetically labile, solvent accessible sources and not from Zn2+ encased in vesicles. In agreement with a previously published result, EDTA chelated approximately 30% of the Zn2+ from the proteome that eluted as a Zn-EDTA complex in the LMW region.24 When the reacted Zn-proteome was probed with Zinquin, the amount of fluorescence was 85% less than that of untreated Zn-proteome. Similar results were obtained using the proteome from TE671 cells. In that system, EDTA again chelated approximately one third of the Zn2+ from the proteomic fraction. However, there was only a 45% depletion of fluorescence from the proteome versus control. In either case, residual fluorescence of the EDTA-treated proteomes does not necessarily mean it is from vesicular compartments, but rather from Zn-sources that are kinetically unfeasible for reaction with the potent chelator. In both EDTA-treated proteomes, the emission spectra were still centered at 470 nm.

These data support the claim that Zinquin interacts with a substantial concentration of soluble Zn-proteins. Moreover, since the Zn-proteome fraction was obtained from sonicated cells after centrifugation at 47,000 g or 100,000 g (next section) and either Sephadex G-75 or Sephacryl S-300 column chromatography, respectively, it is unlikely that liposomal vesicles, and certainly not native vesicles, remained in the Zn-proteome used in these experiments. The finding that the emission maximum of the fluorescent species was centered on 470 nm strongly supports the formation of ZQ-Zn-protein adducts because interaction of Zn(ZQ)2 with liposomes only causes a marginal blue shifted spectrum.17 In results to be presented elsewhere, we show that cytosol remaining after centrifugation at 100,000g was also reactive with ZQ. Thus, we conclude that ZQ reacted with Zn-proteins to form ternary, ZQ-Zn-protein adducts.

To further support that Zinquin reacted with cytosolic Zn-proteins, higher resolution gel filtration was used. The cell lysate of TE671 cells was centrifuged at 100,000g to remove not only cell fragments but any small organelles, such as microsomes, before separation by Sephacryl S-300 chromatography (Figure 5). The resulting chromatograph shows that fluorescence distributed throughout the eluted proteins. Moreover, a substantial amount of Zinquin fluorescence was associated with the molecular weight region from 100,000-10,000 Da, signifying reactivity with the Zn-proteins located within the supernatant. The emission spectra of this pool were again centered near 470 nm.

Figure 5.

Figure 5

Sephacryl S-300 separation of TE671 cytosol. The cytosol of approximately 3 × 108 TE671 cells was run over a Sephacryl S-300 gel filtration column eluted with 50 mM Tris-Cl, 150 mM NaCl, pH 7.4. Fractions were assayed with 5 µM Zinquin Acid. Approximate molecular weights of eluted fractions were determined using gel filtration standards.

Reactions of ZQEE/ZQACID with model Zn-proteins

To further investigate the reactivity of Zinquin with Zn-proteins, a model Zn-protein, Alcohol Dehydrogenase (Zn2-ADH), was titrated with ZQEE and ZQACID. ADH is a homodimer with each monomer containing 2 Zn2+ ions, one catalytic Zn2+ located within the active site and one structural Zn2+ that is solvent inaccessible.2 As Zn2-ADH was titrated with ZQEE, the fluorescence intensity increased with an emission spectrum maximum centered at 471 nm, consistent with the formation of a ZQEE-Zn2-ADH ternary adduct (Figure 6). After eluting the reaction mixture using Sephadex G-50 gel filtration, indeed all fluorescence and Zn2+were located in the proteome region. The fluorescence maximum remained at 471 nm, further supporting formation of a ternary adduct.

Figure 6.

Figure 6

Zinquin reactivity with Zn2-ADH. (A) 5 µM Zn2-ADH (10 µM Zn total) titrated with increasing amounts of Zinquin Ethyl Ester in 20 mM Tris-Cl pH 7.4 at 25 °C. (B) Fractional saturation vs. concentration of Zinquin Ethyl Ester for the titration in Figure 5A. (C) Sephadex G-50 seperation of the resulting titration in (A) showing fluorescence confined to the proteomic fractions. (D) 5 µM Zn2-ADH (10 µM total Zn2+) titrated with increasing amounts of Zinquin Acid in 20 mM Tris-Cl pH 7.4 at 25 °C. (E) Sephadex G-50 fractionation of 5 µM Zn2-ADH with 10 µM Zinquin Acid showing chelation of half of the Zn2+ from Zn2-ADH.

To determine any differences between the ethyl ester and acid forms, the experiment was repeated again, this time using ZQACID. Upon titration, the fluorescent again increased but with a λmax centered at 479nm. Upon elution, two pools of fluorescence and Zn2+ were separated, one in the proteomic region and one in the LMW region. The proteomic region, containing half the total Zn2+, exhibited a fluorescence spectrum that was blue-shifted to 472 nm, similar to that seen with ZQEE. The other half of the total Zn2+ was located in the LMW region and displayed a fluorescence spectrum characteristic of Zn(ZQACID)2 centered at 492nm. These data confirmed that ZQACID not only can form a ternary adducts with Zn-proteins, but also was able to extract Zn2+ from native Zn-proteins. Further investigation is needed to determine which of the 2 Zn2+ centers in the protein underwent ligand substitution reaction with ZQACID.

Titration with ZQEE was repeated with another Zn-protein, alkaline phosphatase. In this case, the fluorescence increased with a spectrum maximum at 475 nm, indicative of forming a ZQEE-Zn2-AP ternary adduct. The observed dissociation constant for this adduct was 6.2 × 10−7 M (Figure 7). When the reacted protein was chromatographed, all the fluorescence and Zn2+ were confined to the proteomic fractions with the spectral maximum at 473nm. These results provide additional support for the hypothesis that Zinquin can form ternary adducts with proteins.

Figure 7.

Figure 7

Zinquin reactivity with Zn2-AP. (A) 5 µM Zn2-AP (10 µM Zn total) titrated with increasing amounts of Zinquin Ethyl Ester in 20 mM Tris-Cl pH 7.4 at 25 °C. (B) Fractional saturation vs. concentration of Zinquin Ethyl Ester for the titration in Figure 6A. (C) Sephadex G-50 fractionation of the titration of Zn2-AP with Zinquin Ethyl Ester showing fluorescence confined to the proteomic fractions. (D) 5 µM Zn2-AP (10 µM total Zn2+) titrated with increasing amounts of Zinquin Acid in 20 mM Tris-Cl pH 7.4 at 25 °C. (E) Sephadex G-50 fractionation of 5 µM Zn2-AP with 10 µM Zinquin Acid showing chelation of half of the Zn2+ from Zn2-AP.

When this titration was carried out with ZQACID, the fluorescence spectrum was not blue-shifted and, instead, revealed the emission profile of free Zn(ZQACID)2 complex. The chromatographed product showed that most of the fluorescence eluted in the LMW region; the residual fluorescence in the proteomic fractions was due to the natural fluorescence of Zn2-AP. In addition, half of the Zn2+ eluted separately from the protein. These data indicate that ZQACID chelated one of the two Zn2+ ions associated with Zn-AP, but was not reactive with the other Zn2+ still bound to the protein.

A third Zn-protein, carbonic anhydrase, was tested for reactivity with Zinquin. Previous work demonstrated that TSQ was able to bind Zn-CA strongly with a dissociation constant ca. 1.5 × 10−7 M.19 When Zn-CA was titrated with either ZQEE or ZQACID, no observable fluorescence increase was observed, indicating that Zinquin is not reactive with Zn-CA. A possible reason for this difference between the reactivities of Zinquin and TSQ with Zn-CA is that the methyl group at the 2 position of the quinoline ring on Zinquin sterically hinders the approach of Zinquin to the active site Zn2+. Studies are on-going to understand the structural basis of the different behavior of Zinquin and TSQ with Zn-CA.

Comparative reactions of TSQ and ZQACID with the Zn-proteome

Since there appear to be differences between the reactivity of TSQ and Zinquin with both model proteins and the Zn-proteome, there may be differences within the sets of Zn-proteins that these fluorophores image within the cellular milieu. To test this hypothesis, the isolated Zn-proteome was further separated by anion exchange chromatography (Figure 8). Upon reaction of the resultant fractions with either ZQACID or TSQ, the two fluorescence profiles were quite different. In some cases, fractions were fluorescent when assayed with either TSQ or ZQACID. In other cases, fractions displayed reactivity with only one of the fluorophores. In either circumstance, the spectra of the reactive fractions were blue-shifted as seen in previous experiments. These data demonstrate that these fluorophores are reactive with a different but overlapping subset of Zn-proteins within the Zn-proteome.

Figure 8.

Figure 8

TSQ/ZQ reactivity with TE671 proteome. Isolated proteome was further separated by ion-exchange chromatography and reacted separately with 5 µM Zinquin Acid (□) and TSQ (○). The resulting fluorescence pattern show that the each sensor reacts with differing subsets of the Zn-proteome.

Discussion

A variety of fluorescent sensors (S) have been synthesized with the aim to image cellular Zn2+.8,29 Mammalian cells contain µM concentrations of Zn2+.30 Almost all of it exists in the form of Zn-proteins, perhaps as many as 3,000.1 As a result, cellular free Zn2+ concentration resides in the high-pM to low-nM range.31,32

Conceptually, for reaction 3 to occur, both its equilibrium and kinetic properties

Zn-protein+SZn-S+protein    (K,k) (5)

must be favorable. Thus, the operative language is that sensors react with labile, loosely bound, or available Zn2+. These adjectives are sensor specific in that various sensors display a range of stability constants for Zn2+ and because of their different structures may be expected to undergo ligand substitution reactions with Zn-proteins at different rates.18

This perspective suggests that sensors may be able to react with members of the Zn-proteome. A recent study showed that between 20–35% of the proteomic Zn2+ from LLC-PK1 cells was reactive with competing ligands that form one to one complexes with Zn2+ when µM Zn2+ as Zn-proteome was reacted with near stoichiometric concentrations of ligands.24 The apparent stability constants of these multidentate ligands in one to one complexes with Zn2+ ranged from 17.6 to 8.0. Thus, a significant fraction of proteomic Zn2+ may be available for ligand substitution reaction with sensors.

Beyond reaction 5, the multi-dentate nature of Zn2+ sensors suggests the possibility that adduct formation might result from reaction of sensors with Zn-proteins. Many Zn-proteins are enzymes that utilize Zn2+ at the active site to coordinate one of the molecules undergoing catalytic reaction.2 As such, they have open ligand binding sites that, in principle, could interact with the sensor to establish a ternary adduct species:

Zn-protein+SSZn-protein (6)

A key paper by Hendrickson et al demonstrated the propensity of the commonly used Zn2+ sensor, Zinquin, to form ternary complexes with small organic ligands.25 The binding affinities of these Zinquin-Zn-adducts were comparable and some cases higher than that of a Zn(ZQ)2 complex, which may lead to preferential adduct formation within a cellular environment. In addition, some adducts identified were characterized by fluorescence emission spectra that were blue-shifted in comparison with Zn(ZQACID)2. Similarly, we have shown that the related sensor, TSQ, reacts in cells to form adduct species that are located in the proteome and characterized by blue-shifted spectra.19 In this context, comparative experiments were undertaken with Zinquin to determine whether the behavior of TSQ extends to ZQ and how the differences in structure of the two sensors might alter their reaction with cells.

To elucidate the source of Zinquin-induced fluorescence, spectrofluorimetry was employed. This method provided greater detail than fluorescence microscopy about the nature of Zn2+ sites to which the fluorophore is bound. By measuring entire emission spectra for a large population of cells instead of the emission intensity of a few cells at a single wavelength, we observed that the emission spectra of a number of cell types exposed to ZQEE were different than the spectra of either Zn(ZQEE)2 or Zn(ZQACID)2 (Table 1). All exhibited similar blue-shifted wavelength maxima near 470 nm in comparison to the reference spectra centered at 490 nm. The blue-shift was also observed with TSQ and is consistent with the formation of ternary adducts between ZQ and Zn-proteins.19

A companion result showed that the observed fluorescence represented 15–30% of the all the cellular Zn2+ in the various cell types. Since previous estimates of total Zn2+ range among the hundreds of micromolar, it was evident that ZQ imaged micromolar not nanomolar concentrations of Zn2+.30,33 This conclusion implied that any hypothesis about the origin of the ZQ-based fluorescence must invoke the Zn-proteome pool as a significant source.

Cellular distribution of Zinquin fluorescence was briefly examined by Coyle et. al. in primary liver extracts exposed to Zinquin in vitro.26 In that system, fluorescence was found in not only the proteomic Zn2+ pool, but also in the MT and LMW pools. In contrast, Zn-MT did not react with Zinquin according to our experiments with intact cells as well as in vitro additions of Zinquin to the metallothionein pool. The discrepancy could possibly be accounted for by the previous use of an extremely high concentration of Zinquin (500 µM) in vitro as well as possible solvent effects due to a high concentration of DMSO (10%) employed in that work.

We tested the generality of our findings by surveying the reaction of ZQEE in a number of cell or tissue types. To our knowledge, this is the first extensive study investigating the intracellular targets of Zinquin in a variety of different cell types. Our exposure time and Zinquin concentration in buffered saline coincided with the parameters used in numerous microscopic experiments.10,1215,22,34 The measured fluorescence intensities of ZQEE treated cells indicated that micromolar concentrations of Zn2+ were being imaged in each cell type (Table 1). For the conversion of fluorescence intensities into concentrations, we used the standard curve for Zn(ZQACID)2. Based on previous observations, adducts between ZQACID and a number Zn-ligand complexes exhibited emission quantum yields of the same order of magnitude as Zn(ZQACID)2.19,25 Other experiments have demonstrated that there are extremely low quantities of intracellular ‘free’ Zn2+ that are in the nM-pM range.30,32 The fact that we detected much more intense fluorescence emission supported our hypothesis that Zn-proteins not Zn2+ ions were the fluorescent species imaged by ZQACID. This view was further corroborated by fractionating the cell lysates and testing their reactivity with EDTA to show that, indeed, the main source of Zinquin induced fluorescence resides in the proteome (Figures 3 and 5).

Zinquin reacted somewhat differently with each cell type. Upon reaction of ZQEE with kidney LLC-PK1 cells and the gel filtration fractionation of its supernatant, the only source of Zinquin fluorescence was within the proteome. However, in other cell types, not only was the proteome fluorescent, but generally small pools of free Zn(ZQACID)2 were also isolated. Its concentration varied among the different cells that were assayed from 5–20% (Table 3). Since low molecular weight Zn2+ was not detected when unexposed cells were fractionated, this result indicated that Zinquin competed for protein bound Zn2+ as in reaction 7.

Zn-protein+2ZQACIDZn(ZQACID)2+apo-protein (7)

This interpretation was supported when similar results were obtained in the reaction of ZQEE or ZQACID with isolated Zn-proteome that did not contain any LMW Zn2+.

According to our results summarized in reaction 7, Zinquin does not just ‘sense’ free Zn2+ ions, it disturbs Zn2+ distribution within the cell. Interestingly, these low molecular weight pools of Zn2+ and fluorescence were not observed when cells were exposed to TSQ instead of ZQEE.19 The 2:1 stability constant for TSQ for Zn2+ is approximately 1011 (unpublished result) and that of ZQACID about 1014.21 Apparently, the difference was sufficient to prevent TSQ from sequestering Zn2+ from the Zn-proteome. Thus, for TSQ, the Zn-proteome was not a source of labile or loosely bound proteomic Zn2+ as described in reaction 3; for ZQACID it was.

The ability of Zinquin to bind to members of the Zn-proteome as well as to chelate Zn2+ from the proteome was further supported by in vitro reactions of Zn2-ADH and Zn2-AP with ZQACID. With Zn2-ADH, ZQACID was able to form a ternary ZQACID-Zn-protein adduct as identified by its blue-shifted fluorescence emission spectrum and co-migration during gel filtration chromatography. Moreover, it competed for enzyme bound Zn2+ to produce Zn(ZQACID)2. ZQACID also competed effectively for one of the two Zn2+ ions in Zn2-AP. By analogy, the in vivo formation of Zn(ZQACID)2 competes for protein bound Zn2+ and may cause inactivation of functionally important Zn-proteins.

ZQEE displayed a different pattern of reactivity with Zn-proteome and model Zn-proteins than did ZQACID. With isolated Zn-proteome as well as Zn2-ADH and Zn2AP, it formed fluorescent ternary adducts but did not successfully compete for Zn2+ to form Zn(ZQEE)2. The difference in structure between ZQEE and ZQACID resides at the R1 position of the isoquinoline ring in Figure 1. It is proposed that the negative charge of ZQACID favors the formation of Zn(ZQACID)2 over ZQACID-Zn-protein by destabilizing favorable binding interactions between ZQACiD and the protein environment surrounding the Zn2+ site.

The results presented here show that Zinquin like TSQ images Zn-proteins. Thus, the asymmetric distribution of intracellular fluorescence reported for Zinquin represents primarily the location of a subset of the Zn-proteome.10,12,14,22,3437. Nevertheless, the picture is more complicated than that for TSQ because some Zn(ZQACID)2 also forms in cells exposed to ZQEE.

Further investigation of how TSQ and Zinquin react with the proteome shows that these fluorophores are not interchangeable with respect to Zn-protein association. After partial separation of the Zn-proteome by a combination of gel filtration and ion exchange chromatography, TSQ or ZQACID were added to each fraction. The clear result was that the profiles of adduct formation activity were different. TSQ and ZQACID do not necessarily react with the same Zn-proteins.

This conclusion was underscored in the experiments with model Zn-enzymes. Both TSQ and ZQACID bind to Zn2-ADH and Zn2-AP. However, only TSQ reacts with Zn-CA; ZQACID and ZQEE are unreactive with Zn-CA. A structural difference between ZQ and TSQ that could well impact their detailed sites of reaction is the presence of a 2-methyl group on the isoquinoline ring (Figure 1). Located next to the nitrogen atom that binds Zn2+, the steric bulk of the methyl group might well serve as a barrier to adduct formation with some Zn-proteins. Since there appear to be substantial differences in binding specificity among these two sensors, conclusions drawn from microscopy studies using one fluorophore might not be the same if the other fluorophore had been used.

Zinquin binds to multiple Zn-proteins. It is plausible to suggest that adduct formation with open binding sites in Zn-proteins may interfere with the chemistries performed by those proteins. Initial studies of the reaction of ZQACID with Zn2-AP support this claim. Furthermore, Zinquin has an affinity for Cu2+ on the same order as that for Zn2+, but the Cu2+ complex does not fluoresce.13,21 Therefore, Zinquin may also be reactive with Cu-proteins in the same manner as Zn-proteins, but remain fluorescently invisible. Isolation and identification of ternary complexes with ZQ and TSQ need be performed to further understand how these sensors may be affecting metabolism during their residence in cells.

Acknowledgements

Funding for this project was made possible by the NIH grants GM-85114, ES-04026, and ES-04184. We thank Dr. Douglas Lobner at Marquette University for providing samples of neonatal mouse brain cell suspensions and Dr. Christopher Chitambar at the Medical College of Wisconsin for supplying the CCRF-CEM cell line. Ms. Susan Krezoski provided support for the cell culture experiments.

Abbreviations

AAS

atomic absorption spectrophotometry

DPBS

Dulbecco’s phosphate buffered saline

LMW

low molecular weight species

MT

metallothionein

TSQ

6-methoxy-8-p-toluenesulfonamido-quinoline

Zn2-ADH

yeast alcohol dehydrogenase

Zn2-AP

bovine alkaline phosphatase

Zn-CA

bovine erythrocyte carbonic anhydrase

ZQAcid

Zinquin acid, (2-methyl-8-p-toluenesulfonamido-6-quinolyloxy)acetate)

ZQEE

Zinquin ethyl ester, ethyl(2-methyl-8-p-toluenesulfonamido-6-quinolyloxy)acetate)

References

  • 1.Andreini C, Banci L, Bertini I, Rosato A. J Proteome Res. 2006;5:196. doi: 10.1021/pr050361j. [DOI] [PubMed] [Google Scholar]
  • 2.Vallee BL, Auld DS. Biochemistry. 1990;29:5647. doi: 10.1021/bi00476a001. [DOI] [PubMed] [Google Scholar]
  • 3.Zhang B, Georgiev O, Hagmann M, Gunes C, Cramer M, Faller P, Vasak M, Schaffner W. Mol. Cell. Biol. 2003;23:8471. doi: 10.1128/MCB.23.23.8471-8485.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Budde T, Minta A, White JA, Kay AR. Neuroscience. 1997;79:347. doi: 10.1016/s0306-4522(96)00695-1. [DOI] [PubMed] [Google Scholar]
  • 5.Kay AR, Toth K. Sci. Signal. 2008;1:re3. doi: 10.1126/stke.119re3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Shen H, MacDonald R, Bruemmer D, Stromberg A, Daugherty A, Li X-a, Toborek M, Hennig B. The Journal of Nutrition. 2007;137:2339. doi: 10.1093/jn/137.11.2339. [DOI] [PubMed] [Google Scholar]
  • 7.Song Y, Leonard SW, Traber MG, Ho E. The Journal of Nutrition. 2009;139:1626. doi: 10.3945/jn.109.106369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jiang P, Guo Z. Coordination Chemistry Reviews. 2004;248:205. [Google Scholar]
  • 9.Frederickson CJ, Kasarskis EJ, Ringo D, Frederickson RE. Journal of Neuroscience Methods. 1987;20:91. doi: 10.1016/0165-0270(87)90042-2. [DOI] [PubMed] [Google Scholar]
  • 10.Haase H, Beyersmann D. Biochemical and Biophysical Research Communications. 2002;296:923. doi: 10.1016/s0006-291x(02)02017-x. [DOI] [PubMed] [Google Scholar]
  • 11.Kaltenberg J, Plum LM, Ober-Blöbaum JL, Hönscheid A, Rink L, Haase H. European Journal of Immunology. 2010;40:1496. doi: 10.1002/eji.200939574. [DOI] [PubMed] [Google Scholar]
  • 12.Truong-Tran AQ, Ruffin RE, Zalewski PD. American Journal of Physiology - Lung Cellular and Molecular Physiology. 2000;279:L1172. doi: 10.1152/ajplung.2000.279.6.L1172. [DOI] [PubMed] [Google Scholar]
  • 13.Zalewski PD, Forbes IJ, Betts WH. Biochem J. 1993;296(Pt 2):403. doi: 10.1042/bj2960403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zalewski PD, Millard SH, Forbes IJ, Kapaniris O, Slavotinek A, Betts WH, Ward AD, Lincoln SF, Mahadevan I. Journal of Histochemistry & Cytochemistry. 1994;42:877. doi: 10.1177/42.7.8014471. [DOI] [PubMed] [Google Scholar]
  • 15.Haase H, Beyersmann D. BioMetals. 1999;12:247. doi: 10.1023/a:1009232311677. [DOI] [PubMed] [Google Scholar]
  • 16.Nasir MS, Fahrni CJ, Suhy DA, Kolodsick KJ, Singer CP, O'Halloran TV. Journal of Biological Inorganic Chemistry. 1999;4:775. doi: 10.1007/s007750050350. [DOI] [PubMed] [Google Scholar]
  • 17.Snitsarev V, Budde T, Stricker TP, Cox JM, Krupa DJ, Geng L, Kay AR. Biophysical Journal. 2001;80:1538. doi: 10.1016/S0006-3495(01)76126-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Petering DH. Chemtracts-Inorganic Chemistry. 2004;17:569. [Google Scholar]
  • 19.Meeusen JW, Tomasiewicz H, Nowakowski A, Petering DH. Inorg Chem. 2011 doi: 10.1021/ic200478q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Reyes JG, Santander M, Martinez PL, Arce R, Benos DJ. Biological Research. 1994;27:49. [PubMed] [Google Scholar]
  • 21.Fahrni CJ, O'Halloran TV. J Am Chem Soc. 1999;121:11448. [Google Scholar]
  • 22.St. Croix CM, Wasserloos KJ, Dineley KE, Reynolds IJ, Levitan ES, Pitt BR. American Journal of Physiology - Lung Cellular and Molecular Physiology. 2002;282:L185. doi: 10.1152/ajplung.00267.2001. [DOI] [PubMed] [Google Scholar]
  • 23.Paoletti P, Vergnano AM, Barbour B, Casado M. Neuroscience. 2009;158:126. doi: 10.1016/j.neuroscience.2008.01.061. [DOI] [PubMed] [Google Scholar]
  • 24.Rana U, Kothinti R, Meeusen J, Tabatabai NM, Krezoski S, Petering DH. Journal of Inorganic Biochemistry. 2008;102:489. doi: 10.1016/j.jinorgbio.2007.10.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hendrickson KM, Geue JP, Wyness O, Lincoln SF, Ward AD. J Am Chem Soc. 2003;125:3889. doi: 10.1021/ja020685y. [DOI] [PubMed] [Google Scholar]
  • 26.Coyle P, Zalewski PD, Philcox JC, Forbes IJ, Ward AD, Lincoln SF, Mahadevan I, Rofe AM. Biochem. J. 1994;303:781. doi: 10.1042/bj3030781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pulido P, Kägi JHR, Vallee BL. Biochemistry. 1966;5:1768. doi: 10.1021/bi00869a046. [DOI] [PubMed] [Google Scholar]
  • 28.Namdarghanbari MA, Meeusen J, Bachowski G, Giebel N, Johnson J, Petering DH. Journal of Inorganic Biochemistry. 2010;104:224. doi: 10.1016/j.jinorgbio.2009.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kimura E, Koike T. Chemical Society Reviews. 1998;27:179. [Google Scholar]
  • 30.Krężel A, Maret W. Journal of Biological Inorganic Chemistry. 2006;11:1049. doi: 10.1007/s00775-006-0150-5. [DOI] [PubMed] [Google Scholar]
  • 31.Outten CE, O'Halloran VT. Science. 2001;292:2488. doi: 10.1126/science.1060331. [DOI] [PubMed] [Google Scholar]
  • 32.Vinkenborg JL, Nicolson TJ, Bellomo EA, Koay MS, Rutter GA, Merkx M. Nat Meth. 2009;6:737. doi: 10.1038/nmeth.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Palmiter RD, Findley SD. EMBO Journal. 1995;14:639. doi: 10.1002/j.1460-2075.1995.tb07042.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Colvin RA. American Journal of Physiology - Cell Physiology. 2002;282:C317. doi: 10.1152/ajpcell.00143.2001. [DOI] [PubMed] [Google Scholar]
  • 35.Colvin RA, Laskowski M, Fontaine CP. Brain Research. 2006;1085:1. doi: 10.1016/j.brainres.2006.02.043. [DOI] [PubMed] [Google Scholar]
  • 36.Spahl DU, Berendji-Grün D, Suschek CV, Kolb-Bachofen V, Kröncke K-D. Proceedings of the National Academy of Sciences. 2003;100:13952. doi: 10.1073/pnas.2335190100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pearce LL, Wasserloos K, St. Croix CM, Gandley R, Levitan ES, Pitt BR. The Journal of Nutrition. 2000;130:1467S. doi: 10.1093/jn/130.5.1467S. [DOI] [PubMed] [Google Scholar]

RESOURCES